Find a Supplier
ADD YOUR COMPANY
CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation
Contact Us Subscribe to Newsletter
Contact Supplier

Contact Supplier

To get in touch with Evercyte GmbH, simply fill out the form below.

    Subscribe to Supplier

    Subscribe to Supplier

    .
    CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation

    Evercyte GmbH White Papers

    Find the latest White Papers from Evercyte GmbH

    Page 1 of 1
    CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation
    CD46 knock-out using CRISPR/Cas9 editing of hTERT immortalized human cells modulates complement activation

    Tuesday 25th February 2020

    By  Evercyte GmbH
    Page 1 of 1
    Full Supplier Profile